Viewing Study NCT03016533

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:44 AM
Ignite Modification Date: 2026-03-12 @ 5:54 PM
Study NCT ID: NCT03016533
Status: COMPLETED
Last Update Posted: 2025-01-14
First Post: 2017-01-06
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Dolutegravir Study in HIV-1 Participants Completing IMPAACT Studies P1093 and P2019
Sponsor: ViiV Healthcare
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Dolutegravir View
None Continued access study View
None HIV-1 View
None ABC/DTG/3TC View
None Pediatric View